1. Home
  2. IMXI vs PLRX Comparison

IMXI vs PLRX Comparison

Compare IMXI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$15.80

Market Cap

469.3M

Sector

Technology

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.36

Market Cap

81.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
PLRX
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
81.1M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
IMXI
PLRX
Price
$15.80
$1.36
Analyst Decision
Buy
Hold
Analyst Count
3
4
Target Price
$16.67
$2.67
AVG Volume (30 Days)
320.6K
558.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.97
EPS
1.08
N/A
Revenue
$319,601,000.00
N/A
Revenue This Year
$0.28
N/A
Revenue Next Year
$0.41
N/A
P/E Ratio
$14.63
N/A
Revenue Growth
16.68
N/A
52 Week Low
$8.58
$1.09
52 Week High
$15.90
$1.95

Technical Indicators

Market Signals
Indicator
IMXI
PLRX
Relative Strength Index (RSI) 55.64 56.43
Support Level $15.73 $1.12
Resistance Level $15.81 $1.36
Average True Range (ATR) 0.04 0.07
MACD -0.01 0.01
Stochastic Oscillator 41.18 87.50

Price Performance

Historical Comparison
IMXI
PLRX

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: